Media Inquiries

Beth Calitri

Corporate Communications, Media Relations

978.417.2031

[email protected]
Sort by Year
August 10, 2011

Ironwood Pharmaceuticals to Present at Wedbush Securities 2011 Life Sciences Management Access Conference

August 9, 2011

Ironwood and Forest Announce Submission of New Drug Application for Linaclotide for the Treatment of Irritable Bowel Syndrome With Constipation and Chronic Constipation

August 8, 2011

Ironwood Pharmaceuticals to Host Second Quarter 2011 Investor Update Call

July 27, 2011

Ironwood Pharmaceuticals and Depomed Announce Collaboration, Research and License Agreement

May 31, 2011

Ironwood Pharmaceuticals Announces Upcoming Presentations at Jefferies Global Healthcare Conference and Goldman Sachs Annual Global Healthcare Conference

May 12, 2011

Ironwood Pharmaceuticals Provides First Quarter 2011 Investor Update

May 5, 2011

Ironwood Pharmaceuticals to Host First Quarter 2011 Investor Update Call

May 4, 2011

Ironwood Pharmaceuticals Announces Upcoming Presentation at Bank of America Merrill Lynch 2011 Health Care Conference

March 3, 2011

Ironwood Pharmaceuticals Announces Upcoming Presentation at Cowen and Company Annual Health Care Conference

March 3, 2011

Ironwood Pharmaceuticals Provides Fourth Quarter 2010 Investor Update

February 28, 2011

Ironwood Pharmaceuticals to Host Fourth Quarter 2010 Investor Update Call

January 18, 2011

Ironwood and Protagonist Establish Collaboration for Peptide Drug Discovery and Development

January 6, 2011

Ironwood Pharmaceuticals Announces Upcoming Presentation at J.P. Morgan Healthcare Conference

November 5, 2010

Ironwood Pharmaceuticals Announces Upcoming Presentation at Credit Suisse 2010 Healthcare Conference

November 4, 2010

Ironwood Pharmaceuticals Provides Third Quarter 2010 Investor Update

Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.